Showing results (81-90 of 114) with videos related to

Sort By:
Pageof 12
The British Journal of Ophthalmology|October 31, 2008
Intravitreal bevacizumab (Avastin) treatment of choroidal neovascularisation in patients with angioid streaksT W Wiegand, A H Rogers, F McCabe, et al.
Ophthalmology|April 1, 1995
Optical sectioning of the cornea with a new confocal in vivo slit-scanning videomicroscopeW Wiegand, A A Thaer, P Kroll, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|February 9, 2000
Heme oxygenase-1 inhibits TNF-alpha-induced apoptosis in cultured fibroblastsI Petrache, L E Otterbein, J Alam, et al.
Reproductive Toxicology (Elmsford, N.Y.)|February 7, 1998
Periconceptional vitamin A use: how much is teratogenic?R K Miller, A G Hendrickx, J L Mills, et al.
Clinical and Diagnostic Laboratory Immunology|July 17, 1998
Expression of adhesion molecules and CD28 on T lymphocytes during human immunodeficiency virus infectionS W Park, W Royal, R D Semba, et al.
American Journal of Respiratory Cell and Molecular Biology|February 26, 1998
Transcriptional activation of the HO-1 gene by lipopolysaccharide is mediated by 5' distal enhancers: role of reactive oxygen intermediates and AP-1S L Camhi, J Alam, G W Wiegand, et al.
Ophthalmologica. Journal International D'Ophtalmologie. International Journal of Ophthalmology. Zeitschrift Fur Augenheilkunde|January 1, 1995
Endogenous fluorescence of ocular malignant melanomasW Lohmann, W Wiegand, T R Stolwijk, et al.
British Journal of Anaesthesia|January 1, 1993
Effects of etomidate on the adrenocortical and metabolic adaptation of the neonateT A Crozier, C Flamm, C P Speer, et al.
British Journal of Clinical Pharmacology|November 1, 1988
Interactions between cilazapril and propranolol in man; plasma drug concentrations, hormone and enzyme responses, haemodynamics, agonist dose-effect curves and baroreceptor reflexG G Belz, J Essig, C H Kleinbloesem, et al.
Clinical Pharmacology and Therapeutics|June 1, 1983
Isosorbide dinitrate kinetics and dynamics after intravenous, sublingual, and percutaneous dosing in anginaR A Morrison, U W Wiegand, E Jähnchen, et al.
Pageof 12